References
- Smith E R, Hadidian Z, Mason M M. The single and repeated dose toxicity of dimethyl sulfoxide. Ann NY Acad Sci 1967; 141: 96–109
- Bond G R, Curry S C, Dahl D W. Dimethylsulphoxide-induced encephalopathy (letter). Lancet 1989; 1: 1134–5113
- Yellowlees P, Greenfield C, McIntyre N. Dimethylsulphoxide-induced toxicity. Lancet 1980; 2: 1004–1006
- Dhodapkar M, Goldberg S L, Tefferi A, Gertz M A. Reversible encephalopathy after cryopreserved peripheral stem cell infusion. Am J Hematol 1994; 45: 187–188
- Higman M A, Port J D, Beauchamp N J, Jr, Chen A R. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000; 26: 797–800
- Zambelli A, Poggi G, Da Pradda G A, Pedrazzoli P, Cuomo A, Miotti D, et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705–4708
- Abrahamsen J F, Rusten L, Bakken A M, Bruserud O. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5% dimethylsulfoxide instead of 10% dimethylsulfoxide. Transfusion 2004; 44: 785–789
- Del Mastro L, Venturini M, Viscoli C, Bergaglio M, Signorini A, Bighin C, et al. Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. Ann Oncol 2001; 12: 505–508
- Calmels B, Houzé P, Hengesse J -C, Ducrot T, Malenfant C, Chabannon C. Preclinical evaluation of an automated closed fluid management device: Cytomate™, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003; 31: 823–828